Decreased Nesfatin-1 Level in Overweight Depressed Patients

Area of Science:

• Neuroendocrinology
• Psychiatry
• Metabolic research

Background:

• Nesfatin-1 (NF-1) is implicated in emotional state modulation, including depression.
• Investigating NF-1's role in major depressive disorder (MDD) is crucial for understanding its pathophysiology.

Purpose of the Study:

• To examine the association between plasma NF-1 levels and MDD.
• To explore the relationship between NF-1, overweight status, and depression severity.

Main Methods:

• Enzyme Linked Immunosorbent Assay (ELISA) was used to quantify plasma NF-1.
• Plasma NF-1 levels were compared between 73 MDD patients and 71 healthy controls.

Main Results:

• MDD patients exhibited significantly lower plasma NF-1 levels compared to healthy individuals (p=0.019).
• Overweight MDD patients had lower plasma NF-1 than non-overweight MDD patients (p=0.024).
• Plasma NF-1 showed negative correlations with age (p=0.033), BMI (p=0.011), and HAM-D scores (p=0.026).

Conclusions:

• Plasma NF-1 levels are significantly related to MDD and overweight status.
• NF-1 may be involved in nervous system pathologies and adipose tissue function.
• These findings suggest NF-1 as a potential biomarker for MDD and related metabolic conditions.